Tony Dickherber, SLAS Committee member, and Program Director at the National Cancer Institute (NCI), discusses emerging technologies in cancer diagnostics and monitoring, including high-speed, high-throughput, multiplex assays, and how they contribute to developing effective cancer treatments.